These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1470 related articles for article (PubMed ID: 33850328)

  • 1. Advances in immunotherapy for hepatocellular carcinoma.
    Sangro B; Sarobe P; Hervás-Stubbs S; Melero I
    Nat Rev Gastroenterol Hepatol; 2021 Aug; 18(8):525-543. PubMed ID: 33850328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent developments with immunotherapy for hepatocellular carcinoma.
    Waidmann O
    Expert Opin Biol Ther; 2018 Aug; 18(8):905-910. PubMed ID: 29995439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunological landscape and immunotherapy of hepatocellular carcinoma.
    Prieto J; Melero I; Sangro B
    Nat Rev Gastroenterol Hepatol; 2015 Dec; 12(12):681-700. PubMed ID: 26484443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strategies to Improve the Antitumor Effect of Immunotherapy for Hepatocellular Carcinoma.
    Xing R; Gao J; Cui Q; Wang Q
    Front Immunol; 2021; 12():783236. PubMed ID: 34899747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: Opportunities and Challenges.
    Liu X; Qin S
    Oncologist; 2019 Feb; 24(Suppl 1):S3-S10. PubMed ID: 30819826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunotherapy for Hepatocellular Carcinoma: Current Status and Future Prospects.
    Liu Z; Liu X; Liang J; Liu Y; Hou X; Zhang M; Li Y; Jiang X
    Front Immunol; 2021; 12():765101. PubMed ID: 34675942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The liver cancer immune microenvironment: Therapeutic implications for hepatocellular carcinoma.
    Donne R; Lujambio A
    Hepatology; 2023 May; 77(5):1773-1796. PubMed ID: 35989535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NASH limits anti-tumour surveillance in immunotherapy-treated HCC.
    Pfister D; Núñez NG; Pinyol R; Govaere O; Pinter M; Szydlowska M; Gupta R; Qiu M; Deczkowska A; Weiner A; Müller F; Sinha A; Friebel E; Engleitner T; Lenggenhager D; Moncsek A; Heide D; Stirm K; Kosla J; Kotsiliti E; Leone V; Dudek M; Yousuf S; Inverso D; Singh I; Teijeiro A; Castet F; Montironi C; Haber PK; Tiniakos D; Bedossa P; Cockell S; Younes R; Vacca M; Marra F; Schattenberg JM; Allison M; Bugianesi E; Ratziu V; Pressiani T; D'Alessio A; Personeni N; Rimassa L; Daly AK; Scheiner B; Pomej K; Kirstein MM; Vogel A; Peck-Radosavljevic M; Hucke F; Finkelmeier F; Waidmann O; Trojan J; Schulze K; Wege H; Koch S; Weinmann A; Bueter M; Rössler F; Siebenhüner A; De Dosso S; Mallm JP; Umansky V; Jugold M; Luedde T; Schietinger A; Schirmacher P; Emu B; Augustin HG; Billeter A; Müller-Stich B; Kikuchi H; Duda DG; Kütting F; Waldschmidt DT; Ebert MP; Rahbari N; Mei HE; Schulz AR; Ringelhan M; Malek N; Spahn S; Bitzer M; Ruiz de Galarreta M; Lujambio A; Dufour JF; Marron TU; Kaseb A; Kudo M; Huang YH; Djouder N; Wolter K; Zender L; Marche PN; Decaens T; Pinato DJ; Rad R; Mertens JC; Weber A; Unger K; Meissner F; Roth S; Jilkova ZM; Claassen M; Anstee QM; Amit I; Knolle P; Becher B; Llovet JM; Heikenwalder M
    Nature; 2021 Apr; 592(7854):450-456. PubMed ID: 33762733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunotherapy for hepatocellular carcinoma: Current and future.
    Johnston MP; Khakoo SI
    World J Gastroenterol; 2019 Jun; 25(24):2977-2989. PubMed ID: 31293335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging immunotherapy for HCC: A guide for hepatologists.
    Foerster F; Gairing SJ; Ilyas SI; Galle PR
    Hepatology; 2022 Jun; 75(6):1604-1626. PubMed ID: 35253934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune checkpoint blockade in advanced hepatocellular carcinoma: an update and critical review of ongoing clinical trials.
    Harding JJ
    Future Oncol; 2018 Sep; 14(22):2293-2302. PubMed ID: 29663837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advancements in Immunotherapeutic Treatments for Hepatocellular Carcinoma: Potential of Combination Therapies.
    Zarlashat Y; Mushtaq H; Pham L; Abbas W; Sato K
    Int J Mol Sci; 2024 Jun; 25(13):. PubMed ID: 38999940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatocellular Carcinoma Immune Landscape and the Potential of Immunotherapies.
    Giraud J; Chalopin D; Blanc JF; Saleh M
    Front Immunol; 2021; 12():655697. PubMed ID: 33815418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel immunotherapy strategies for hepatobiliary cancers.
    DeLeon TT; Zhou Y; Nagalo BM; Yokoda RT; Ahn DH; Ramanathan RK; Salomao MA; Aqel BA; Mahipal A; Bekaii-Saab TS; Borad MJ
    Immunotherapy; 2018 Sep; 10(12):1077-1091. PubMed ID: 30185133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New Frontiers in the Medical Therapy of Hepatocellular Carcinoma.
    Fulgenzi CAM; D'Alessio A; Talbot T; Gennari A; Openshaw MR; Demirtas CO; Cortellini A; Pinato DJ
    Chemotherapy; 2022; 67(3):164-172. PubMed ID: 34999584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spontaneous and therapeutic immune responses in hepatocellular carcinoma: implications for current and future immunotherapies.
    Wirth TC
    Expert Rev Gastroenterol Hepatol; 2014 Jan; 8(1):101-10. PubMed ID: 24410473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current status and perspectives of immune-based therapies for hepatocellular carcinoma.
    Aerts M; Benteyn D; Van Vlierberghe H; Thielemans K; Reynaert H
    World J Gastroenterol; 2016 Jan; 22(1):253-61. PubMed ID: 26755874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potentiality of immunotherapy against hepatocellular carcinoma.
    Tsuchiya N; Sawada Y; Endo I; Uemura Y; Nakatsura T
    World J Gastroenterol; 2015 Sep; 21(36):10314-26. PubMed ID: 26420958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunotherapy of Hepatocellular Carcinoma: Facts and Hopes.
    Iñarrairaegui M; Melero I; Sangro B
    Clin Cancer Res; 2018 Apr; 24(7):1518-1524. PubMed ID: 29138342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From bench to bed: the tumor immune microenvironment and current immunotherapeutic strategies for hepatocellular carcinoma.
    Fu Y; Liu S; Zeng S; Shen H
    J Exp Clin Cancer Res; 2019 Sep; 38(1):396. PubMed ID: 31500650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 74.